U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07514897) titled 'Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring' on March 31.
Brief Summary: This study will, for the first time, establish a non-invasive diagnostic model for bladder cancer based on CREPT expression levels in exfoliated urothelial cells using a multicenter cohort, and validate its value in the non-invasive diagnosis and recurrence monitoring of bladder cancer. Its high sensitivity is expected to overcome the technical limitations of existing biomarkers and provide an innovative solution for establishing an integrated precision diagnosis and treatment system encompassing "screening, diagnosis, and monitoring."...